Doctor Harini de Silva

Senior Research Officer, Immunocompromised Host Translational Research Program


Harini de Silva’s background is in immunology and infectious disease. She has broad experience in the areas of autoimmunity, allergy, malaria vaccines and infections in the immunocompromised host. In 2002, Harini joined a multidisciplinary team at Monash Microbiology to work on a malaria vaccine development project funded by the Gates Foundation. In 2009 Harini moved to the Burnet Immunomonitoring Facility and managed the quality accreditation project that enabled this facility to become the first NATA accredited R&D laboratory in Victoria. Harini’s current research focuses on diagnostic and biomarker assays for opportunistic and vaccine preventable infections in immunocompromised patients such as those undergoing stem cell transplantation.

Harini has a wide range of skills including cellular and molecular immunology, development and validation of immunoassays, project management, quality management, clinical trial and clinical registry co-ordination and immunology teaching.


  • Member of Australian Society of Immunology (ASI)
  • Member of International Society for Human and Animal Mycology (ISHAM)
  • Member of the Victorian Infection and Immunity Network (VIIN)


  • 2011-Current: Senior Research Officer, Life Sciences Discipline, Burnet Institute
  • 2014-2015: Research Fellow, Department of Epidemiology, Monash University
  • 2009-2011: Project Manager, Burnet ImmunoMonitoring Facility
  • 2002-2009: Research Fellow, Malaria Vaccine Initiative, Monash University
  • 1998-2002: Research Fellow, Department of Immunology, Monash University


  • 2017: MPH, Monash University, Australia
  • 1998: PhD, Monash University, Australia
  • 1992: BSc (Hons), Monash University, Australia

Publications (13)

2014 (1)

2011 (2)

2010 (1)

2008 (1)

2005 (1)

2004 (2)

2000 (2)

1999 (1)

1998 (1)

1996 (1)


Contact Details